The application of ecological momentary assessment (EMA) in community settings provides a powerful opportunity to obtain measures of emotional reactivity to daily life events, as well as emotional dynamics in real time. This investigation examines the association between emotional reactivity to daily events and emotional experience in mood and anxiety disorders in a large community-based sample. Two-hundred and 87 participants with a lifetime history of bipolar I disorder (BPI; n ϭ 33), bipolar II disorder (BPII; n ϭ 37), major depression (MDD; n ϭ 116), anxiety disorders without a mood disorder (ANX; n ϭ 36), and controls without a lifetime history of mood, anxiety, or substance use disorder (n ϭ 65) completed a 2-week EMA evaluation period concerning mood states and daily events. Following positive events, individuals with BPI reported greater decreases in both sad and anxious mood than did controls, and individuals with MDD experienced greater decreases in anxious mood. Following negative events, the BPII, MDD, and ANX (but not BPI) groups experienced greater increases in anxious mood, with no group differences in sad mood. Greater variability and instability were observed for sad mood in the BPII and MDD groups, and greater variability and instability was observed for anxious mood in all of the mood/anxiety groups. However, no group differences were observed for the inertia of sad or anxious moods. The findings demonstrate differences in emotional reactivity to daily events as well as the general affective dynamics of emotional states among individuals with mood or anxiety disorders, with potential specificity for BPI disorder relative to other disorders. Emotional variability and instability may constitute a nonspecific characteristic of both mood and anxiety disorders.
General Scientific Summary
This study suggests that responses to positive and negative daily events differ by subtypes of mood disorders. Both reactivity and stability of emotional states among people with BPI disorder differ from those with BPII, MDD, and anxiety disorders, confirming emerging evidence from studies of familial and clinical features for distinguishing BPI from these other subgroups.
Keywords: ecological momentary assessment, bipolar disorder, depressive disorder, reactivity, variability Supplemental materials: http://dx.doi.org/10.1037/abn0000378.supp There has been growing attention to the underlying mechanisms that may constitute increased vulnerability to mood and anxiety disorder onset or episode recurrence (Brown & Barlow, 2009 ). While mood may fluctuate over time for any given individual, the possibility that persons with these disorders may experience reliable differences in mood reactivity has been suggested by previous research concerning both major and minor events (e.g., Bylsma, Taylor-Clift, & Rottenberg, 2011; Husky, Mazure, Maciejewski, & Swendsen, 2009; Mazure & Druss, 1995; Peeters, Nicolson, Berkhof, Delespaul, & DeVries, 2003; Starr, Hammen, Connolly, & Brennan, 2014; Stroud, Davila, & Moyer, 2008; Thompson et al., 2012; Uliaszek et al., 2012; Vrshek-Schallhorn et al., 2015) . Findings from diverse research paradigms have also suggested that mood and anxiety disorders may be characterized by differences in the general dynamics of mood experience (e.g., Bowen, Baetz, Hawkes, & Bowen, 2006; Farmer & Kashdan, 2014; Gruber, Kogan, Mennin, & Murray, 2013; Henry et al., 2008; Thompson, Boden, & Gotlib, 2017) . However, traditional epidemiologic and clinical research protocols have generally relied on retrospective reporting of event exposure that does not capture the rapid fluctuations that are inherent to the experience of momentary mood states and reactivity to daily events. The application of mobile technologies that are capable of assessing within-day changes in mood, notably using ecological momentary assessment (EMA; Ebner-Priemer & Trull, 2009; Husky et al., 2010; Johnson et al., 2009; Shiffman, Stone, & Hufford, 2008; Walz, Nauta, & aan het Rot, 2014) , has provided a powerful opportunity to obtain measures in real time of reactivity to daily life events as well as of the affective dynamics of individuals with mood or anxiety disorders.
Among the different views that have been formulated regarding alterations in emotional reactivity in mood disorders, emotion context insensitivity (ECI) proposes that individuals with depression experience reduced positive and negative emotional responses to positive and negative events (Rottenberg, Gross, & Gotlib, 2005) . A meta-analysis of laboratory studies comparing adults with mood disorders to controls yielded support for the ECI view as major depression was associated with a reduced emotional reactivity to both types of stimuli (Bylsma, Morris, & Rottenberg, 2008) . In contrast, the negative potentiation and positive attenuation hypotheses posit that major depression is associated with greater reactivity to negative events and reduced reactivity to positive events, respectively. The negative potentiation hypothesis is consistent with Beck's cognitive model of depression describing the priming of distorted cognitive information processing (Beck, 1987) , while the positive attenuation hypothesis accounts for reductions in emotional responses to positive stimuli due to anhedonia as well as the overall motivational deficits that are frequent in this disorder (Depue & Iacono, 1989) .
Previous EMA studies examining emotional reactivity following daily life events have yielded mixed results. For instance, one investigation reported increased negative emotions in reaction to daily negative events among individuals with prior depression as compared with controls , while another controlled EMA study reported that participants with depression exhibited smaller increases in negative emotions following negative events as well as a "mood brightening" effect characterized by greater decreases in negative emotions following positive events (Peeters et al., 2003) . In addition, the latter study reported that decreases in positive emotions following negative events were of significantly smaller magnitude in participants with depression compared with controls, while increases in positive affect following positive events were larger in the former group. A third study found no significant differences between participants with and without depression regarding changes in positive emotions following either positive or negative events, or relative to increases in negative emotions following negative events (Bylsma et al., 2011) . However, a mood-brightening effect was again observed in this investigation, whereby greater decreases in negative emotions occurred following positive events in participants with major depression or subthreshold depression compared with controls. Interestingly, these authors also observed that mood brightening was still apparent when controlling for baseline mood, suggesting that this effect could not be accounted for solely by high levels of prevailing negative mood among individuals with mood disorders. Thompson et al. (2012) observed a similar mood-brightening effect for depressed participants, but these individuals did not differ from controls concerning positive affect following positive events, or positive or negative affect following negative events. In summary, with the exception of mood brightening that was observed across three investigations examining this effect (Bylsma et al., 2011; Peeters et al., 2003; Thompson et al., 2012 ) the findings of previous EMA studies are inconsistent concerning differences in emotional reactivity between individuals with and without depression. Such inconsistency may be explained by numerous factors including the presence of comorbidity, the nature of the event itself, and the clinical state of the participants at the time of the study (aan het Rot, Hogenelst, & Schoevers, 2012; Bylsma et al., 2011; Havermans, Nicolson, Berkhof, & DeVries, 2010; Peeters et al., 2003; Tan et al., 2012; Vrshek-Schallhorn et al., 2015) .
In addition to emotional reactivity to events, the affective dynamics among people with different disorders have been frequently examined by three distinct metrics: emotional variability, instability, and inertia (see Houben, Van Den Noortgate, & Kuppens, 2015; Trull, Lane, Koval, & Ebner-Priemer, 2015; Trull et al., 2008) . Estimates of emotional variability, or the range or amplitude of emotional states across time, is most often calculated by the within-person standard deviation or variance of emotions (Eid & Diener, 1999) . Emotional instability refers to the magnitude of emotional changes from one moment to the next and it is typically calculated as the mean squared successive difference between consecutive emotion scores (von Neumann, Kent, Bellinson, & Hart, 1941) ; emotional inertia refers to the autocorrelation between consecutive measures of emotion as an index of the moment-to-moment consistency of affect (Kuppens, Allen, & Sheeber, 2010; Suls, Green, & Hillis, 1998) . The EMA studies that have tracked emotional variability in mood disorders in real time have observed greater variability in negative affect among those with depression (Koval, Pe, Meers, & Kuppens, 2013; Wichers et al., 2010) , as well as in both subtypes of bipolar disorder (Schwartz, Schultz, Reider, & Saunders, 2016) .
While there is more limited research on anxiety disorders, greater variability in positive affect has also been observed in these individuals (Morgan et al., 2017) . Greater mood instability has been observed in individuals with major depression (Thompson et al., 2012 ; for contrasting findings see Koval et al., 2013) , bipolar disorder (Jones, Hare, & Evershed, 2005) , and anxiety disorders (Pfaltz, Michael, Grossman, Margraf, & Wilhelm, 2010) . Finally, a recent meta-analysis of this literature revealed that greater emotional inertia (in addition to variability and instability) is associated with increases in anxiety and depressive symptoms (Houben et al., 2015) . However, these authors also underscore the differences that each metric may reveal concerning the emotional dynamics of specific syndromes. For example, individuals with more severe forms of depression demonstrated lower variability of positive emotions, consistent with the presence of anhedonia. These latter conclusions remain tentative, however, as the findings of a recent EMA study that was specific to anhedonia observed greater variability of positive emotions in these individuals (Heininga, van Roekel, Ahles, Oldehinkel, & Mezulis, 2017) .
While previous studies have shed considerable light on mood reactivity and affective dynamics in these clinical samples, several methodological and conceptual issues have impeded broader conclusions from the existing literature. First, most studies have not included large samples affected by different subtypes of mood disorder, nor have they systematically examined the concomitant role of anxiety disorders (Pfaltz et al., 2010; Tan et al., 2012) . Such comparisons are essential for understanding how emotional regulation differs between specific mental disorders (Rottenberg, 2017) . Similarly, the accumulation of studies using bivariate comparisons (examining one disorder relative to a control group) render findings difficult to compare across studies due to the methodological differences that can be observed in EMA research designs and measures. Considering that the majority of individuals affected by these conditions do not seek treatment (Kessler et al., 2005) , it is also important to note that samples in most previous investigations have been recruited from clinical settings that may not generalize to the general population because of the increased severity and comorbidity of disorders reflected in clinical settings (Galbaud du Fort, Newman, & Bland, 1993) . Only two of the previously cited EMA investigations of affective dynamics have recruited participants from the general community (i.e., Bylsma et al., 2011; Thompson et al., 2012) . Finally, previous studies have not systematically controlled for pharmacological treatment or current disorder status or other factors that have a major impact on these phenomena. Tests of these models may therefore be advanced through the application of homogeneous methods addressing a larger diversity of disorder subtypes drawn from community samples, and with consideration for episode status and for the medications prescribed for these conditions.
The present investigation employs EMA over a 2-week period in a large sample recruited from a community setting. The primary aims are to evaluate differences in emotional reactivity to daily events as well as the variability, instability, and inertia of emotional states among different mood disorder subtypes, anxiety disorders, and controls. Consistent with the negative potentiation perspective, we hypothesize that individuals with mood or anxiety disorders will experience greater increases than controls in sad and anxious mood following negative events. We also hypothesize a mood brightening effect whereby greater reductions in sad and anxious mood will be observed following positive events. Based on previous EMA studies, those with either mood or anxiety disorders are also expected to exhibit greater variability, instability and inertia in both sad and anxious moods as compared to controls.
Method Sample
A sample of 287 participants from the National Institute of Mental Health (NIMH) Family Study of Affective Spectrum Disorders, a large community-based controlled family study of probands with DSM-IV-TR mood and anxiety disorders was used. Probands were recruited from a community screening of the greater Washington, DC metropolitan area, other local sources through the NIH Clinical Center general volunteer referral core, local health newsletters and announcements, or from screens of participants in the NIMH Mood and Anxiety Disorder Program to enrich the sample for mood disorders. The community sample, designed to be a nontreatment/nonclinical sample of persons with and without mental health disorders, was ascertained by mail contact through a marketing list of households within 50 miles of Washington, DC. Inclusion criteria were the ability to speak English and availability and consent to contact at least two living first-degree relatives. The study was approved by the Combined Neuroscience IRB at the National Institutes of Health (NIH; protocol no. 03-M-0211). All individuals provided written informed consent to participate. More details of the family study methods are presented elsewhere (Merikangas et al., 2014) . For the present study, we included only participants 18 years and older who had a lifetime diagnosis of bipolar I (BPI), bipolar II (BPII), major depression (MDD), anxiety disorders without mood disorders (ANX; including generalized anxiety disorder [GAD] , panic disorder, social phobia, specific phobia, agoraphobia, obsessivecompulsive disorder, posttraumatic stress disorder, separation anxiety), and unaffected controls. Most prevalent among the ANX group were specific phobia (63.9%), GAD (27.8%), and social phobia (19.4), and the majority (72.2%) had more than one anxiety diagnosis. The majority of probands were euthymic at the time of assessment; 62.2% of cases were current, defined as the presence of an active diagnosis in the past year (see Table 1 ).
Procedures
Diagnostic assessments. Standard family study methodology was employed, including direct diagnostic interviews of probands and relatives by experienced clinicians, systematic enumeration of all relatives, and blind assessment (Merikangas et al., 2014) . The NIMH Structured Diagnostic Interview for Mental and Medical Disorders was based on the adaptation of the diagnostic interview used in prior family studies of anxiety and substance use disorders at the Yale University School of Medicine Genetic Epidemiology Research Unit . This interview ascertains diagnostic criteria for current and lifetime DSM-IV-TR disorders, but does not adhere to strict diagnostic criteria for skip-outs based on frequency or duration at the probe level in order to capture subthreshold phenomenology across the key domains of psychopathology for multiple diagnostic systems (Angst, Dobler-Mikola, & Binder, 1984; Angst et al., 2005) . The NIMH Family Study Family History Interview was used to assess a family history of psychiatric disorders based on modifications of the family history interview from previous family study research . The interview was based on the core structure of the Family History-Research Diagnostic Criteria (FH-RDC) developed for the collaborative family study of affective disorders (Andreasen, Rice, Endicott, Reich, & Coryell, 1986) . Best estimate diagnoses for this study were based on all available information by a team of experienced clinicians (psychologists, psychiatrists, and clinical social workers; Leckman, Sholomskas, Thompson, Belanger, & Weissman, 1982) . Interrater reliability of the diagnoses was excellent (ICC ϭ Ͼ0.87) for all major diagnostic categories (Merikangas et al., 2014) .
Ecological momentary assessment (EMA). Participants in the EMA phase of the study were asked to fill out an electronic questionnaire on a Personal Digital Assistant (Tungsten E2 PDA) four times per day over a 2-week period (56 assessments in total). The choice of four assessments per day was based on previous EMA findings indicating that mood changes remain significant over a 3-to 6-hr period following daily event occurrence (Johnson et al., 2008) . Concerning assessments schedules, each day was divided into four "epochs" that spanned the majority of waking hours for each individual. Each participant was then signaled one time in each epoch, within a 2-to 6-hr window (the minimal spacing between any two assessments was at least 2 hr, and occurred on average every 4 hr). Signaling schedules were adapted to accommodate for the individual's usual sleep/wake cycles so that early risers would start their four epochs earlier and finish earlier, while late risers would begin and finish later. The assessment signals occurred at fixed moments for each participant and that were randomized across participants. All participants received training from a research assistant on how to use the PDA and how to fill out the questionnaire. Research assistants contacted each participant after the start of the EMA measurements to verify that they understood study procedures and that the PDA device was functioning properly. The EMA assessments included questions concerning a diversity of daily life experiences and behaviors, including data assessed at the moment of the EMA signal (current location, social company, performance of specific behaviors, mood states) and data assessed over the time period between the current and previous assessment or, for the first assessment of the morn- ing, since awakening (experience of daily events and event negativity, food intake, substance use, experience of headache and its specific symptoms). Additional questions were asked at the first EMA assessment of the day concerning sleep duration, quality and sleep problems, and at the end of the day concerning global ratings of the stressfulness of the day, food craving for the day and specific physical symptoms (gastrointestinal symptoms, muscle pain). The response possibilities included Likert scales for dimensional constructs (such as mood or event negativity) and checklists that allowed for either multiple responses (such as for noting all food types consumed since the last assessment) or single responses (such as current physical location). The content of behavioral and environmental categories was based on previous time budget estimations provided by Brandstätter (1994) as well as previous EMA research (Bouisson & Swendsen, 2003; Granholm, Loh, & Swendsen, 2008; Salomon, Swendsen, & Husky, 2013) , and for all other questions was based on consultation with experts in corresponding fields concerning sleep, headache, and nutrition. For the purpose of this investigation, only questions concerning continuous scales of mood states and daily event negativity were exploited. The mood questions were based on Larsen and Diener's mood circumplex (Larsen & Diener, 1992) , with adjectives describing diametrically opposed mood states reflecting either positive and negative mood states as well as low or high arousal states. Separate 7-point Likert scales were constructed to measure the degree to which participants felt very happy (1) to very sad (7), as well as very calm (1) to very anxious (7). All mood scores were centered across the grand-median and all days for each of the four assessments per day separately. For daily events, participants were asked at each assessment to identify the one event or experience, good or bad, that had affected them the most since the last questionnaire, and to rate the impact the event had on them on a 7-point Likert scale ranging from extremely positive (1) to extremely negative (7) with event categories modeled from the inventory of small life events (Zautra, Guarnaccia, & Dohrenwend, 1986) . This impact variable was recoded into three categories that indicated positive events (score 1-3), neutral events (score 4), or negative events (score 5-7).
Statistical Analyses
All analyses were conducted in SPSS v22 using the statistical significance threshold of p Ͻ .05. Linear mixed model analyses were applied to account for the hierarchical structure of the data (observations nested within persons), and can take into account the dependencies among observations. Models were performed using mood states as the outcome variable and with diagnostic group, event type (positive, negative, or neutral [reference]), diagnostic group ‫ء‬ event type, and mood states at the previous assessment as fixed effects. Maximum likelihood estimation was used. We modeled a repeated effect (multiple observations per participants) using an AR(1) correlation structure to account for the correlation between subsequent measurements, which assumes a first-order autoregressive structure with homogenous variances which is reasonable given the longitudinal nature of the data, and with a random effect (intercept) for subject. For a more comprehensive description of multilevel models, see Twisk (2006) . Variability, instability, and inertia of mood states were analyzed with ANOVA models including group (BPI, BPII, MDD, anxiety, and controls
[reference]), adjusting for variation in age and sex, and the number of days used in calculating the outcome. Mood variability was based on the average standard deviation (SD) of all (noncentered) assessments within a day for a given mood state. In addition, we evaluated measures of instability by calculating average withinday mean squared successive difference (MSSD), and inertia by means of average within-day autocorrelation. MSSD was transformed as LN(MSSD ϩ1) to normalize distribution. Because the high correlation between especially SD and MSSD (Ͼ0.8) would introduce collinearity problems, we analyzed the three measures separately, not correcting for the other measures of variability. A random effect of family was ignored as previous analyses failed to demonstrate a significant effect for this variable. All models were performed with and without adjustments for past 30-day medication use (including antidepressants, mood stabilizers, and anxiolytic medications; data not shown). Table 1 presents the sociodemographic characteristics, rates of comorbid anxiety disorders, EMA completion rates, and EMA ratings of the number and valence of events by the mood disorder subgroups. The average age of the sample (N ϭ 287) was 48.2 years (SD ϭ 16.5, range 18 -84) and 63.4% were female. Proportions of those with a lifetime history of anxiety disorders were greatest among individuals with BPI (84.3%), followed by those with BPII (75.7%) and MDD (68.1%); these differences were not statistically significant.
Results

Sample Description and EMA Compliance
On average, each participant completed 44 (SD ϭ 10.0) out of 56 electronic assessments (78.5%; range 3-56 assessments, median IQR ϭ 47 (40 -51); 60.3% of the sample completed Ն80% of the assessments. In total, the number of available EMA assessments was 12,618 for sad mood and 12,626 for anxious mood. EMA compliance did not differ significantly by age, sex, or diagnostic category. Participants reported on average 8.2 neutral events (SD 7.2), 7.4 negative events (SD 6.6), and 28.3 positive events (SD 12.0) over the course of the study. There was no significant difference in the number of reported neutral events between diagnostic groups, F(4, 282) ϭ 0.490, p ϭ .74. However, there were significant differences in the number of reported positive, F(4, 282) ϭ 2.739, p ϭ .03), and negative events, F(4, 282) ϭ 4.644, p ϭ .001, with controls reporting significantly fewer negative events than all diagnostic groups and more positive events than persons with either BP I or BP II. Figure 1 shows the average mood intensity across groups, revealing that those with MDD, BPI, and BPII had significantly higher average sad and anxious mood scores compared with controls. Those with BPII also had higher average anxious mood scores than MDD and ANX only. BPI had a higher average sad and anxious mood compared with controls, MDD, and ANX only.
Mood Intensity and Reactivity
There were significant main effects of positive and negative events on the severity of both sad and anxious mood states, with positive events improving mood states and negative events worsening mood states (see Table 2 In post hoc analyses, we evaluated the effect of current diagnosis and comorbid anxiety disorder in MDD. For this, we conducted the same models as previously presented while splitting the MDD group into current and remitted subgroups, and in a separate model Note. All models adjusted for age and sex. Significant findings shown in bold text. Based on a mixed linear model with an AR(1) covariance structure for repeated measures, and a random intercept for subject.
for those with and without comorbid anxiety disorder. This was done only for those with MDD as this group as this was the only one large enough to allow for these analyses. The results of these post hoc analyses showed a similar pattern of effects for current and remitted MDD for both outcomes (see Supplementary Table  1 ). In contrast, the MDD group with comorbid anxiety showed different patterns from the MDD group without comorbidity. Those with comorbid anxiety showed a stronger increase in anxious mood following negative events than controls (B ϭ 0.474, 0.127, t(7799.373) ϭ 3.743, p Ͻ .0001), whereas those without comorbid anxiety did not have a significantly different response from controls. For sad mood, the MDD group with comorbid anxiety also showed increased sad mood following negative events, while the MDD group without comorbidity showed decreased sad mood following negative events as compared with controls. However, both of these latter interaction terms did not reach statistical significance. MDD without comorbid anxiety also showed decreased sad mood following positive events as compared with controls (B ϭ Ϫ0.199, 0.101, t(7847.298 ) ϭ Ϫ1.971, p ϭ .049), an effect that was not observed in MDD with comorbidity.
Mood Variability, Instability, and Inertia
Compared with controls, significantly increased variability was observed in those with BPII for both sad and anxious moods (BPII B sad mood ϭ 0.151, t t(278) ϭ 2.717, p ϭ .007; B anxious mood ϭ 0.255, t(278) ϭ 23.627, p Ͻ .001), whereas those with MDD and with ANX showed increased variability for anxious mood only (MDD: B anxious mood ϭ 0.198, t(278) ϭ 3.735, p Ͻ .0001; ANX: B anxious mood ϭ 0.188, t(278) ϭ 2.650, p Ͻ .00; see Table 3 ). Analyses of the instability measures showed that all groups had increased instability in anxious mood compared to controls (BPI B ϭ 0.241, t(277) ϭ 2.491, p ϭ .01; BPII B ϭ 0.353, t(277) ϭ 3.835, p ϭ .01; MDD B ϭ 0.248, t(277) ϭ 3.561, p Ͻ .0001; ANX B ϭ 0.234, t(277) ϭ 2.507, p ϭ .01). Increased instability was also found for sad mood in MDD and BPII (MDD B ϭ 0.132, t(277) ϭ 2.237, p ϭ .03; ANX B ϭ 0.181, t(277) ϭ 2.310, p ϭ .02; see Table 3 ). By contrast, no differences were observed in any of the inertia outcomes (see Table 3 ). Again, these findings did not differ substantially when controlling the use of medications that may affect mood variability. When adjusting for presence of a current disorder, estimates of increased variability and instability in anxious mood attenuated somewhat for BPI and ANX, but no main effect of mood/anxiety disorder was observed (p Ͼ .05).
Post hoc analyses were conducted to evaluate the effect of current diagnosis and comorbid anxiety disorder in MDD, similarly as was done for the reactivity analyses. These results showed were no markedly different estimates of variability for the current and remitted MDD groups compared with controls. Having comorbid anxiety, however, seemed to impact variability in the MDD group; both SD and MSSD estimates were significantly higher in the comorbid group versus controls, but this was not observed for those without comorbidity (see Supplementary  Table 2) . 
Discussion
Using ecological momentary assessment, we investigated potential differences in mood reactivity to daily events and affective dynamics in a large community-based sample that included individuals with major depression, bipolar I and II disorders, anxiety disorders, and controls. Partial support was found for our hypotheses concerning differences for mood reactivity as well as for different patterns of affective dynamics by diagnostic subgroups. Contrary to both ECI and positive attenuation perspectives, but consistent with our hypothesis of mood brightening, individuals with BPI exhibited greater reductions in both sad and anxious mood states following positive events. This effect was also observed for anxious mood in individuals with MDD. Partial support was also found for our hypothesis of negative potentiation following negative events. In particular, no differences were observed for any disorder subgroup concerning the intensity of sad mood following negative events, but BPII, MDD, and ANX (and not BPI) groups did experience greater increases in anxious mood following these same events. The differential reactivity to daily events among those with BPI provides further support for distinguishing this disorder from other mood subtypes, as also suggested by emerging evidence from studies of familial aggregation (Merikangas et al., 2014; Vandeleur, Merikangas, Strippoli, Castelao, & Preisig, 2014) and clinical features of BPI, BPII, and MDD (Cuellar, Johnson, & Winters, 2005; Faurholt-Jepsen et al., 2015) .
Concerning affective dynamics, individuals with BPII exhibited greater variability in sad mood compared with controls, and all diagnostic groups demonstrated greater variability in anxious mood. For mood instability, BPII and MDD demonstrated greater instability in sad mood compared with controls, and all disorder groups experienced greater instability in anxious mood. Taken together, these findings are therefore generally consistent with the meta-analysis by Houben, Van Den Noortgate, and Kuppens (2015) demonstrating the association of mood variability or instability with decreased psychological well-being. Contrary to our hypotheses and that of Houben et al. (2015) , however, no differences were found in mood inertia for any of the disorder groups in comparison to controls. In this way, individuals with mood or anxiety disorders would not appear to be more resistant to emotional change than individuals without mood or anxiety disorders (and despite other differences in mood reactivity or affective dynamics). Moreover, the lack of specificity of mood variability or instability suggests that these phenomena cannot be considered as pathognomonic of any of the disorder categories we examined and has several possible interpretations. First, it may suggest that emotional variability or instability constitute a general vulnerability factor for a larger range of mental disorders than has been previously acknowledged (Meyer & Hofmann, 2005) . Support for this interpretation may be found if longitudinal investigations can document that an increased risk of disorder onset, relapse rates, or clinical severity is associated with the degree of emotional variability or instability. Conversely, the lack of such an association may indicate that these mood differences are either a consequence of these syndromes, or a potential endophenotype with no direct impact on their clinical course or outcome. The presence of increased emotional variability or instability among unaffected family members of probands with these disorders would provide one source of support for this latter possibility.
In post hoc analyses, we evaluated the effects of current versus remitted MDD and of MDD with and without comorbidity. Interestingly, patterns of effects did not differ markedly for current and remitted MDD for both reactivity and variability. This finding is suggestive of more of a trait than state effect, and it is in line with studies showing that some remitted patients still exhibit increased reactivity compared to controls ). On the other hand, previous studies have found that affective reactivity normalizes after treatment (aan het Rot et al., 2012) . Our findings indicate that those with MDD and comorbid anxiety disorder have generally greater effect estimates for reactivity and instability than those without comorbid anxiety. Greater instability was recently observed to be associated with trait anxiety but not with depression (Heller, Fox, & Davidson, 2018) which could explain these findings. In addition, comorbid cases may represent more severe forms of psychopathology than MDD without comorbidity.
Our current analyses showed more effects for the outcome of anxious mood than for sad mood, and this is somewhat surprising for the sample under study. While the scales used for both mood states vary in affect negativity and in arousal, it is possible that anxious mood is more reactive to daily life events than sad mood. Along these same lines, the variance for sad mood was somewhat lower than for anxious mood, making that there was simply more variance in anxious mood to be explained.
A main strength of this investigation is its use of repeated electronic mobile assessments of emotional states and daily events in real time (thus minimizing retrospective recall biases; Stone, Shiffman, Schwartz, Broderick, & Hufford, 2003) . The simultaneous evaluation of BPI, BPII, MDD, and anxiety disorders also facilitated our ability to examine the specificity of emotional reactivity and affective dynamics with respect to unaffected controls, and relative to comorbid anxiety disorders that are common in mood disorder subtypes. The integration of current (past year) diagnostic status as well as medication use into statistical models did not substantially affect the findings. As such, the results are unlikely to simply reflect state characteristics of these disorders or the potential influence of pharmacotherapy. Finally, the community-based nature of the sample further supports the generalization of findings to the broader population.
The present findings should be interpreted in light of several limitations of its methods and instruments. The mood states used for analyses of both reactivity and affective dynamics were chosen based on a theoretical model of emotions that includes positive and negative affective states, each characterized by different degrees of activation. In addition, only a limited selection of emotional states was examined and therefore the present study differs from other investigations examining a wider range of emotions (e.g., Trampe, Quoidbach, & Taquet, 2015) . These emotions were also assessed using bidimensional scales (e.g., happy and sad mood states were assessed on a single continuum). Such scales are consistent with the theoretical framework of mood used in this study (Larsen & Diener, 1992) , but differ from many previous investigations that have used unidimensional scales to assess individual mood states or that have assessed positive and negative affect independently. Concerning this latter point, depression severity is associated with a stronger bipolar relationship between positive and negative affect (Dejonckheere et al., 2018) , and therefore such associations may not be adequately characterized using bipolar scales.
The heterogeneity of the anxiety group used in this study also precludes specific conclusions concerning differences by disorder subtype. In addition, the EMA assessments were limited to a 2-week period and therefore we could not determine the stability of these findings over longer periods of observation. Future research is needed to examine the stability of these differences, as well as the extent to which other forms of emotional dysregulation may comprise underlying endophenotypes that index heterogeneity of the spectrum of mood and comorbid disorders. Inclusion of additional factors that can influence mood states, such as sleep quality and exercise (Pemberton & Fuller Tyszkiewicz, 2016) , should also be considered in future research in order to provide a more thorough characterization of emotional dysregulation in these populations.
